المؤلفون: Katherine E.R. Smith, MD, Stephanie L. Pritzl, MD, Wei Yu, PhD, Ilze Bara, MD, Gita Thanarajasingam, MD, Monika D. Kaul, MD, Kirstin A. Williams, PhD, CNP, Amylou C. Dueck, MD, Aaron S. Mansfield, MD

المصدر: JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100611- (2023)

مصطلحات موضوعية: Immune-related adverse events, Immune checkpoint inhibitors, Non–small cell lung cancer, Atezolizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364323001546Test; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/e5e782b7f8e347ce8ef0b2845d17c3ffTest

المؤلفون: Jianhua Zhang, Hao Xu, Alexandre Reuben, Brian Alexander, Jack Lee, Tina Cascone, Jianjun Zhang, Kyle G Mitchell, Marcelo V Negrao, Stephen G Swisher, John V Heymach, Don L Gibbons, Jack A Roth, Ferdinandos Skoulidis, Yasir Y Elamin, Xiuning Le, Anne Tsao, Chang-Jiun Wu, Vincent A Miller, Bonnie S Glisson, Karthikeyan Murugesan, Meagan Montesion, Garrett Frampton, Katja Schulze, Ilze Bara, Vincent Shen, Sylvia Hu, Dawen Sui, Michael E Goldberg, David S Barreto, Jacqulyne P Robichaux, Carl M Gay, Lingzhi Hong, Waree Rinsurongkawong, Vassiliki Papadimitrakopoulou, Gaurav Singal, Lee A Albacker, David Shames

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://jitc.bmj.com/content/9/8/e002891.fullTest; https://doaj.org/toc/2051-1426Test

الوصول الحر: https://doaj.org/article/deb634044c5641f5a4d7746a8b39b598Test

المؤلفون: Naoyuki Nogami, Mark A. Socinski, Delvys Rodriguez-Abreu, Federico Cappuzzo, Makoto Nishio, Daniil Stroyakovskiy, Anthony Lee, Gene Grant Finley, Geetha Shankar, Tony Mok, Christian Thomas, Robert M. Jotte, Ilze Bara, Shelley Coleman, Fabrice Barlesi, David Merritt, Denis Moro-Sibilot, Wei Yu, Francisco Orlandi, Darren Wan-Teck Lim, Martin Reck, Liza C. Villaruz, Joachim G.J.V. Aerts

المساهمون: Pulmonary Medicine, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), German Center for Lung Research, CHU de Grenoble-Alpes, Moscow City Oncology Hospital, National Stream and Aquatic Ecology Center, Biological and Physical Resources Staff, USDA

المصدر: Journal of Thoracic Oncology, 17(2), 309-323. International Association for the Study of Lung Cancer
JOURNAL OF THORACIC ONCOLOGY
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (2), pp.309-323. ⟨10.1016/j.jtho.2021.09.014⟩

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Population, Antibodies, Monoclonal, Humanized, Carboplatin, chemistry.chemical_compound, Atezolizumab, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Chemotherapy, education.field_of_study, Intention-to-treat analysis, Brain Neoplasms, business.industry, Liver Neoplasms, Hazard ratio, Brain, ErbB Receptors, Liver, Paclitaxel, chemistry, Mutation, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d28ac16d7f223dfc27864765b1d672Test
https://doi.org/10.1016/j.jtho.2021.09.014Test

المؤلفون: Marcelo V Negrao, Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bara, Vincent Shen, Hao Xu, Sylvia Hu, Dawen Sui, Yasir Y Elamin, Xiuning Le, Michael E Goldberg, Karthikeyan Murugesan, Chang-Jiun Wu, Jianhua Zhang, David S Barreto, Jacqulyne P Robichaux, Alexandre Reuben, Tina Cascone, Carl M Gay, Kyle G Mitchell, Lingzhi Hong, Waree Rinsurongkawong, Jack A Roth, Stephen G Swisher, Jack Lee, Anne Tsao, Vassiliki Papadimitrakopoulou, Don L Gibbons, Bonnie S Glisson, Gaurav Singal, Vincent A Miller, Brian Alexander, Garrett Frampton, Lee A Albacker, David Shames, Jianjun Zhang, John V Heymach

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Cancer Research, Lung Neoplasms, medicine.medical_treatment, Immunology, medicine.disease_cause, B7-H1 Antigen, Cohort Studies, Carcinoma, Non-Small-Cell Lung, Immunotherapy Biomarkers, medicine, ROS1, Immunology and Allergy, Humans, Lung cancer, Immune Checkpoint Inhibitors, neoplasms, RC254-282, Pharmacology, Oncogene, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Oncogenes, medicine.disease, Immune checkpoint, Progression-Free Survival, Tumor Burden, Treatment Outcome, Oncology, tumor biomarkers, Cancer research, Molecular Medicine, Biomarker (medicine), Oncogene Fusion, KRAS, immunotherapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93dadef3a1350e21e93ca4213b2afbf0Test
https://jitc.bmj.com/content/9/8/e002891.fullTest

المؤلفون: Katja Schulze, Junheng Gao, Carter Dufrane, Xiaofei Wang, David Kozono, Helen J. Ross, Everett E. Vokes, Ilze Bara, James J. Urbanic, Terence M. Williams, Tom Stinchcombe, Jane Michelle Brockman

المصدر: Journal of Clinical Oncology. 39:8513-8513

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Immune checkpoint inhibitors, medicine.medical_treatment, Stage III NSCLC, Stage III Non-Small Cell Lung Cancer, Atezolizumab, Internal medicine, Medicine, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b9e09b57e655ed633a2a17dca8903d18Test
https://doi.org/10.1200/jco.2021.39.15_suppl.8513Test

المؤلفون: Xiaofei Wang, Katja Schulze, Tom Stinchcombe, JaneMichelle Michelle Brockman, Helen J. Ross, Everett E. Vokes, James J. Urbanic, M. Gandhi, Junheng Gao, Carter Dufrane, Terence M. Williams, David Kozono, Ilze Bara

المصدر: Journal of Clinical Oncology. 38:9045-9045

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Immune checkpoint inhibitors, medicine.medical_treatment, Stage III NSCLC, Stage III Non-Small Cell Lung Cancer, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, Adjuvant, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::83fbae4e2baf0c48c12c3cce6ed9efb5Test
https://doi.org/10.1200/jco.2020.38.15_suppl.9045Test

المؤلفون: Wei Yu, Han A. Koh, Ilze Bara, Marta Batus, Mark Kozloff, Janakiraman Subramanian, Eli Kirshner, Eric H. Bernicker, Kert D. Sabbath, Robert M. Jotte, Mehmet Sitki Copur, Michael Nowicki, Gene Grant Finley

المصدر: Journal of Clinical Oncology. 38:e21637-e21637

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Bulky Disease, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Paclitaxel, Atezolizumab, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8abc9a509f5fe41a467ee7357b779028Test
https://doi.org/10.1200/jco.2020.38.15_suppl.e21637Test

المؤلفون: Joachim Moecks, Denis Soulières, Ilze Bara, Luis Paz-Ares, Barbara Klughammer, Tony Mok

المصدر: Journal of Cellular and Molecular Medicine

مصطلحات موضوعية: Oncology, medicine.medical_specialty, erlotinib, Lung Neoplasms, Afatinib, tyrosine-kinase inhibitor, gefitinib, first line, afatinib, non-small cell lung cancer (NSCLC), non-small-cell lung cancer (NSCLC), Bioinformatics, chemistry.chemical_compound, Gefitinib, Meta-Analysis as Topic, Internal medicine, icotinib, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Epidermal growth factor receptor, Lung cancer, neoplasms, Protein Kinase Inhibitors, biology, business.industry, Cell Biology, Original Articles, medicine.disease, Prognosis, epidermal growth factor receptor (EGFR), Dacomitinib, respiratory tract diseases, ErbB Receptors, Survival Rate, Review Literature as Topic, chemistry, Icotinib, Mutation, biology.protein, Molecular Medicine, Erlotinib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::080a1fc8fc87b9502caf53ebcd97d6b4Test
http://europepmc.org/articles/PMC4190899Test

المؤلفون: Christian A. Thomas, Robert M. Jotte, Frederico Cappuzzo, Howard West, Makoto Nishio, Alan Sandler, Marcus Ballinger, Martin Reck, Naoyuki Nogami, Tony Mok, Francisco Orlandi, Vassiliki A. Papadimitrakopoulou, Fabrice Barlesi, Anthony Lee, Geetha Shankar, D Stroyakovskii, Mark A. Socinski, Ilze Bara, Wei Yu

المصدر: Journal of Clinical Oncology. 37:9012-9012

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Gastroenterology, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Paclitaxel, chemistry, Atezolizumab, 030220 oncology & carcinogenesis, Internal medicine, Medicine, In patient, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfa9c9bf7b6fffe5ff2c2937708144fTest
https://doi.org/10.1200/jco.2019.37.15_suppl.9012Test

المؤلفون: Peter Middel, Barbara Klughammer, Julien Mazieres, Alice Frosch, Gaelle Klingelschmitt, Ilze Bara, Federico Cappuzzo, Wolfram Brugger

المصدر: Lung Cancer. 82:231-237

مصطلحات موضوعية: Male, Oncology, Cancer Research, Pathology, Lung Neoplasms, Gene Expression, 0302 clinical medicine, Non-small cell lung cancer, Biomarkers, Epidermal growth factor receptor, Erlotinib, Immunohistochemistry, Maintenance, Risk Factors, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, 0303 health sciences, education.field_of_study, Cetuximab, biology, Hazard ratio, Middle Aged, ErbB Receptors, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Population, Placebo, 03 medical and health sciences, Internal medicine, medicine, Humans, education, Protein Kinase Inhibitors, Aged, Neoplasm Staging, 030304 developmental biology, business.industry, Confidence interval, biology.protein, Receptor, Epidermal Growth Factor, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc18e083baac1e5259f243ca945efc58Test
https://doi.org/10.1016/j.lungcan.2013.07.016Test